PHARMA FALCON (Latest Edition)
PHARMA FALCON (Latest Edition)
PHARMACOLOGY
PREVIOUS EXAMINATION QUESTIONS (PAPER:
PAPER 1 TOPICS
General pharmacology
Drugs acting on autonomi
2. nervous system
GENERAL PHARMACOLOGY
DEFINITIONS, ROUTES OF DRUG ADMINISTRATION
TRIPATHI KATZUNG SATOSKAR
Essay Questions:
8TH ED
two advantages of 12 42 8
and
8 lwo drugs used sublingually
(Apr. 2008)
sublingual route
(Jan. 84) 12 9
9 Rectal route -
advantage and disadvantages
(Feb. 2018, Jan. 2013) 12
10 Transdermal drugs.
FALCON'S COMPANION FOR SECOND MBBS
2
TRIPATHI KATZUNG SATOSKAR
Short and Very Short Questions
(Apr. 2000) 9 6
10. Inhalation - merits, demerits.
Oct. 87) 13
11. Parentral route definition, two examples.(Aug. 2019,
(Jan.84) 14 7
advantage, disadvantages.
12. Intravenous route -
2001) 13 23
13. New drug delivery system. (Aug.2019, Oct.
route of 14
of intravenous
14. Advantages and disadvantages
(May2007)
drug administration
PHARMACOKINETICS
(Aug. 2019, 42 22
12. Methods of prolongation of drug action.
(Oct. 2008, Apr. 1991)
2. Drug receptors. 48 9 29
(May2006, Jan. 87)
Combined Effects of Drugs:
3. Synergism. (July. 2017, Apr. 90) 66 859 51
66 1082 63
5. Pharmacokinetic drug interactions (Apr. 2008)
67 14 51
6. Antagonism types, examples. (Feb. 2020 (KNR) ;Jan. 2016
-
Oct. 2004, Apr. 2003, Oct. 2002, Oct. 99, 96, Apr. 93)
Essay Questions:
2009) 73 54
1. Factors modifying drug action. (July. 2017, April. 2010,
Oct. 90, 75 58 49
2. Pharmacogenetics. (Aug. 2019, Jan. 2012,
(Oct.90) 94 43
5. Selective toxicity.
(Oct.97)97 134314
6. Adrenaline in anaphylaxis.
FALCON's COMPANION FOR SECOND MRRS
4
OTHER TOPICS
TRIPATHI KATZUNG
Short and Very Short Questions SATOSKAR
Apr. 89) 5
1. Pharmacopiea
(Apr.88) 3 3
2. Sources of drugs.
Short Questions:
Shortand Very
and therapeutic uses of neostigmine. 117
1. Mechanis of action
(Jan.2013)
290
mode of action and uses. (Apr.95) 125,130108,113
Atropine sulphate
-
2 295
Oct. 2001, Apr. 88) 126
substitutes. (Jan. 2012,
3. Synthetic atropine
295
action. (Oct. 87| 131
4. Mydriatic with cydoplegic 117 294
the 132
contraindications for the
use of Atropine. Explain
5. Two (Apr.2008)
rationale 223
in parkinson
131
substitute used
Mention four synthetic atropine
(April.2009)
its role in
the therapy.
(Oct. 2001)
(Apr. 2003)
circulatory failure.
146 130 261
3 Dopamine, Dopamine given by slow IV drip.
(Oct. 96, 93, Apr. 92)
7. Uses of Bz agonist/ Bagonist. (July 2011 ; Oct. 2002, Apr. 85) 242132, 252
340 267
ANTIADRENAGIC DRUGS
Essay Questions
TRIPATHI KATZUNG SATOSKAR
1 Discuss briefly the pharmacology of
B-adrenigic blockers.
Enumerates any, 3 ß-blockers and write 157 138 271
their uses
effects and precautions during use. adverse
(Feb. 2018, Oct. 92, April.
2009)
2. Classify muscarinic receptor antagonists write in
brief the 126 290
pharmacological action and therapeutics uses of atropine.
(Aug. 2010)
3. Classify drugs used in the treatment of hypertension. Write
171,209
the pharmacological actions, uses and adverse effects of
219,175
ACE inhibitors (Antigotensin Converting Enzyme inhibitors) 185
(Jan.2016)
Short and Very Short Questions
1. -Adrenergic blocking agents. (Apr. 2009, 2005, Oct. 88)| 153 140 268
(Mar. 2010)
relaxants.
Write the
mechanism of 374,
muscle
Classify
skeletal choline. 379
2. adverse
effects of Succinyl
uses and (Oct. 2008)
action,
Questions:
Short and Very Short effect.(Oct. 94) 376 447 305
action, side
d - T u b o c u r a r i n e - p h a r m a c o l o g i c a l
1.
mode of
action. (Apr. 2005, | 374 447
307
-
Indications,
2. Succinylcholine Oct. 2002)
succinylcholine.
(Jan. 2014) 379 447 305,307
Compared d-TC with
4. 379 447
(Oct. 2001)| 307
5. Pancuronium.
5 379 447 305
Pancuronium and succinylcholine.
Difference between
6. (May. 2006)
382
dontrolene sodium ? Mention its uses.
LOCAL ANAESTHETICS
witi. 392
5. Pharmacological basis of administration of lignociane
(Oct. 200o)
adrenaline
PHARMACOLOGY
QUESTION BANK
9
ANTIHISTAMINES
1. Mepyramine maleate.
(Apr.86) 175 318
2. Astemizole in allergic rhinitis.
(Oct.92) 181 318
3. Therapeutic uses of antihistamines. (Aur. 2019, Apr. 93) | 182 273 317
4 Difference between loratidine and
promethazine. Basis for 179 273 317
their use in therapy.
(Feb. 2020 (KNR), May. 2006)
5. Mechanism of action of
sumatriptan Apr. 2009) 193 328
SERATONIN ANTAGONISIS
6. Enumerate seratonin antagonists, write their therapeutic 189 281 326
uses. (Apr.2009, Oct. 99)
8 Difference between loratidine and promethazine. Basis for 179 273 317
their use in therapy (May2006)
9 Two advantages of loratidine over Diphenhydramine. 179 275 317
(Apr. 2008)
ACE INHIBITORS
Short Questions
Shortand Very Write any 2 which satisfy| 404
ideal
anaesthetic. 104
Properties of
an
1. (July. 2015)
most of them.
(Oct. 98) 405 422 98
Nitrous oxide.
2. 405 422
Ether merits, demerits.
(Oct. 98, Apr. 97) 95
3.
oxide as general
disadvantages
of nitrous
and
4. Advantages
2017, Jan. 2013) 405
(July.
anaesthetic.
97) 406 422 95
2011, Oct. 2001, Apr.
5. Halothane. (Aug. 2019, Jan.
2002)| 408 430 98
anesthetics.(Oct. 2008, 2004, Apr.
6. Intravenous general
408 430 99
demerits
merits and
sodium -
7 Thiopentone
Oct. 98, 97, Apr. 91)
(Apr. 2000,
intravenous route of 408
disadvantages of
8. Advantages and
drug administration
(Feb. 2019, Jan. 2013)
433 100
(Apr. 93) 411
9 Ketamine. 102
413 431
2016, 2015, Apr. 88, 85, 83)
10. Preanesthetic medication. (Jan. 413 431 103
medication.
preanesthetic
11. Diazepam and atropine in
(Apr. 90)
413 431 103
morphine in
12. Reason for combination of atropine and
(Apr.84)
preanesthetic medication.
101
Short
and VeryShort Questions TRIPATHI KATZUNGSATOSKAR
Essay Questions
Discuss mechanism of action 439, 397, 123,
Classify antiepiliptic drugs.
441 414 134
toxicity and uses of diphenyl hydantoin.
(Feb. 2020 (KNR), 2002, Oct. 98)
FALCON'S COMPANION FOR SECON
12 MB83
TRIPATHI KATZUNG 3ATOSKA
(or)
Discuss in detail pharmaco
antiepileptic drugs. drugs.
Classify of any
three
adverse effects
logical action and (Oct. 90)
(or) of action
mechanism
Discuss
drugs.
Classify antiepileptic drugs used
in grandmal
two
effects of any (Apr. 95)
adverse and
epilepsy
Short and Very Short Questions (Oct. 93) 439 397 123
1. Phenytoin. and 442 400 126
precautions
indications for use,
2 Carbamazepine - (Apr. 2003)
unwanted effects.
439
two uses of Diphenyl hydantoin.
3. Mechanism of action and (Oct. 2008)
442 128
11 Write two uses and two side effects of carbamazepine
(Jan. 2011, Aug. 2009)
ANTIPARKINSONIAN DRUGS
Short and Very Short Questions:
1. Enumerate two classes of drugs used in Parkinsonism. (Apr. 2005 453 447 222
54
(Apr.2009) 73
action.
6. Write factors modifying drug
inhibitors. (Mar. 2021 (NTR), 487
Selective seratonion reuptake Jan. 2016, 2014)
FALCON's cOMPANION FOR SECOND MBBS
14 AND
ANTAGONISTS
ANALGESICS
OPIOID
TRIPATHI KATZUNG SATOSKAR
Essay Questions: of action and 497 512,
mechanism 142
alkaloids.
Discuss
(Oct. 88, 95) 523
1. Classify opium
effects of morphine.
adverse
(or) examples
suitable
Relief, giving List
used of Pain of Morphine.
Classify Drugs
Mechanism
& sites
ofactions for use of Morphine.
Specify the c o n t r a i n d i c a t i o n s
indications
and (Apr. 2003)
the
(or)
pharmacological actions
Write the
analgesics. treatment of
Classify opioid Outline the
of Morphine.
adverse
effects (May 2006)
and
acute Morphine poisoning.
3.
Contraindications
of (July. 2015, 2011,
head injuries/bronchial asthma.
Oct. 99, 89, 87)
Essay Questions:
detail the
209 597 158
1. drugs used as NSAIDs. Discuss in
Enumerate the
adverse
pharmacological actions, therapeutics uses and
effects of any three of them. (Aug.2019, Oct. 2001)
PHARMACOLOGY
QUESTION BANK 15
1. Uses of prostaglandins
(Feb. 2020 (KNR), Oct. 2008) 205
2. Asprin (salicylates) action,
contraindications.
therapeutic uses, 212 599 159
(July. 2017, Apr. 2010, 2009, 99, 90)
3. Rationale of using asprin in myocardial infarction. 2156 0 1 162
(Oct. 2002)
4. Cyclooxygenase-1 inhibitor. (Feb. 2020 (KNR). 221 174
Aug. 2010, 2009)
5. Diclofenac mechanism of action and uses. (Oct. 2004) 220 584, 169,
600 177
7. How does valdecoxib differ from lbuprofen ? Basis for 221 579174
their uses (May. 2007)
8. Therapeutics uses and adverse effects of aspirin.(Mar 2010) 212 467
Apr.84)
343
239 527
33. Cough suppressant. (Oct. 95)
349
2.Iron preparations -adverse effects.(Oct. 93, July 2013, 2011)| 647 531 484,486
Indications for parentral use ofiron (Aug. 2019, Sept. 2003, 651 531 486
Apr. 2005, Sept. 2003, Oct. 89)
649 532 486
4 Mention two parenteral iron preparation and twotherapeutic
uses of them. (July 2017, 2015, Oct. 2004)